Literature DB >> 8527854

Myelin mutants: new models and new observations.

K F Lunn1, M L Fanarraga, I D Duncan.   

Abstract

The myelin mutants have been extensively used as tools to study the complex process of myelination in the central and peripheral nervous system. A multidisciplinary approach to the study of these models ultimately allows a correlation to be made between phenotype and genotype. This correlation may then lead to the formation of new hypotheses about the functions of the products of genes involved in myelination. This review presents a number of new myelin mutants which have recently been described. The species involved include mouse, rat, rabbit, hamster, and dog models. The genetic defect has not been elucidated in all of these animals, but most have been characterized clinically and pathologically, and, in some cases, biochemically. In addition, a better known myelin mutant, the trembler mouse, is discussed. Recent molecular findings have brought this fascinating mutant to the forefront of the field of peripheral nervous system research. The range of abnormalities in the mutants described in this review includes defects in specific myelin proteins, suspected abnormalities in membrane formation, and apparent defects of the oligodendrocyte cytoskeleton. These findings underscore the complexity of the myelination process and highlight the numerous ways in which it can be disrupted.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8527854     DOI: 10.1002/jemt.1070320303

Source DB:  PubMed          Journal:  Microsc Res Tech        ISSN: 1059-910X            Impact factor:   2.769


  11 in total

Review 1.  Restoring the balance between disease and repair in multiple sclerosis: insights from mouse models.

Authors:  Robert H Miller; Sharyl L Fyffe-Maricich
Journal:  Dis Model Mech       Date:  2010-07-20       Impact factor: 5.758

2.  A history of proteolipids: a personal memoir.

Authors:  M B Lees
Journal:  Neurochem Res       Date:  1998-03       Impact factor: 3.996

Review 3.  Schwann cell invasion of the central nervous system of the myelin mutants.

Authors:  I D Duncan; R L Hoffman
Journal:  J Anat       Date:  1997-01       Impact factor: 2.610

4.  Modeling the natural history of Pelizaeus-Merzbacher disease.

Authors:  Joshua A Mayer; Ian R Griffiths; James E Goldman; Chelsey M Smith; Elizabeth Cooksey; Abigail B Radcliff; Ian D Duncan
Journal:  Neurobiol Dis       Date:  2015-01-03       Impact factor: 5.996

5.  Insertion of a retrotransposon in Mbp disrupts mRNA splicing and myelination in a new mutant rat.

Authors:  L T O'Connor; B D Goetz; J M Kwiecien; K H Delaney; A L Fletch; I D Duncan
Journal:  J Neurosci       Date:  1999-05-01       Impact factor: 6.167

6.  Ventilatory impairment in the dysmyelinated Long Evans shaker rat.

Authors:  R A Johnson; T L Baker-Herman; I D Duncan; G S Mitchell
Journal:  Neuroscience       Date:  2010-06-11       Impact factor: 3.590

7.  Fast bound pool fraction imaging of the in vivo rat brain: association with myelin content and validation in the C6 glioma model.

Authors:  Hunter R Underhill; Robert C Rostomily; Andrei M Mikheev; Chun Yuan; Vasily L Yarnykh
Journal:  Neuroimage       Date:  2010-10-26       Impact factor: 6.556

Review 8.  Common mechanisms of compensatory respiratory plasticity in spinal neurological disorders.

Authors:  Rebecca A Johnson; Gordon S Mitchell
Journal:  Respir Physiol Neurobiol       Date:  2013-05-28       Impact factor: 1.931

9.  A mutation in the canine gene encoding folliculin-interacting protein 2 (FNIP2) associated with a unique disruption in spinal cord myelination.

Authors:  Trevor J Pemberton; Sunju Choi; Joshua A Mayer; Fang-Yuan Li; Nolan Gokey; John Svaren; Noa Safra; Danika L Bannasch; Katrina Sullivan; Babetta Breuhaus; Pragna I Patel; Ian D Duncan
Journal:  Glia       Date:  2014-01       Impact factor: 7.452

10.  Human intraretinal myelination: axon diameters and axon/myelin thickness ratios.

Authors:  Thomas FitzGibbon; Zoran Nestorovski
Journal:  Indian J Ophthalmol       Date:  2013-10       Impact factor: 1.848

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.